top of page

A New Frontier in the Fight Against Atherosclerosis

Coronary artery disease is a leading cause of global morbidity and mortality, accounting for 600,000 deaths in the US every year

Endotyping Coronary Artery Disease

PlaqueTec has pioneered a way to profile the underlying biology and is building cohorts to endotype disease for the first time

Inspiring a New Generation of Precision Medicine

PlaqueTec’s unique approach is enabling the identification of new disease-specific drug targets and paving the way for a new era of precision medicine for millions of patients with CAD
bottom of page